Study title:
Heath-John-A, Turner-Christopher-D, Poussaint-Tina-Young, Scott-R- Michael, Goumnerova-Liliana, Kieran-Mark-W.
Department of Pediatric Oncology, Dana-Farber Cancer Institute,
Boston, Massachusetts, USA. john.heath@rch.org.au.
Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.
Pediatric hematology and oncology, {Pediatr-Hematol-Oncol}, Oct-Nov
2003, vol. 20, no. 7, p. 497-504, ISSN: 0888-0018.Heath-John-A, Turner-Christopher-D, Poussaint-Tina-Young, Scott-R- Michael, Goumnerova-Liliana, Kieran-Mark-W.
Department of Pediatric Oncology, Dana-Farber Cancer Institute,
Boston, Massachusetts, USA. john.heath@rch.org.au.
Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|